Skip to main content

Second Mistrial Announced in a J&J Talc Cancer Suit Retrial

Second Mistrial Announced in a J&J Talc Cancer Suit Retrial

Second Mistrial Announced in a J&J Talc Cancer Suit Retrial

Introduction

A second South Carolina jury failed to reach a verdict in a retrial case filed against talcum powder giant Johnson & Johnson involving claims filed by the family of a victim, who died of mesothelioma in 2017, allegedly due to the asbestos exposure from J&J's talcum powder.

Then 30-year-old victim ran a three-person law firm in Columbia along with her husband. Earlier in May, the Darlington County Court of Common Pleas in Charleston was deadlocked in the first trial against J&J. A lawyer representing the family stated that the plaintiffs were unhappy with the mistrial announcement as J&J refused to take responsibility for the damages caused even when the jury urged the parties to consider settlement.  The company continues to deny the presence of asbestos in its talcum products. This is the fifth time the jury has announced a mistrial in a mesothelioma case against J&J as it failed to reach a verdict or because the plaintiff died.

There are about 11,700 lawsuits against J&J, claiming that the company failed to adequately warn consumers about the carcinogenic asbestos presence in its talc-based products causing mesothelioma and ovarian cancer in several individuals. J&J has consistently declined the hazards of its talcum products and is currently appealing all jury verdicts declared against them.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!